Domain Expert Persona: Top-Tier Senior Analyst in Epidemiology and Public Health Policy (focusing on the WHO European Region and Vaccine-Preventable Diseases).
Abstract:
The 2024 review by the European Regional Verification Commission for Measles and Rubella Elimination (RVC) indicates a significant setback in measles control within the WHO European Region. Six Member States—Armenia, Austria, Azerbaijan, Spain, the UK, and Uzbekistan—re-established endemic measles transmission during the reporting period, leading to concern over persistent immunity gaps and insufficient outbreak response capacity across the region. While 60% (32) of Member States maintained elimination status for both measles and rubella, the RVC emphasized that the majority of reported measles cases occurred in unimmunized populations. The Commission reiterated the critical policy recommendation for sustained coverage of at least 95% with two doses of measles- and rubella-containing vaccines to close immunity gaps and reverse the decline in elimination status.
Summary of RVC Findings on Measles and Rubella Elimination Status (2024)
Loss of Measles Elimination Status: Six European Member States—Armenia, Austria, Azerbaijan, Spain, the UK, and Uzbekistan—re-established endemic measles transmission in 2024, resulting in the loss of their elimination status.
Current Endemic States: An additional 11 countries were classified as endemic for measles, including France, Georgia, Germany, Italy, Kazakhstan, Kyrgyzstan, Poland, Romania, Russian Federation, Serbia, and Türkiye.
Sustained Elimination Status: As of the 2024 submissions, 32 (60%) of Member States provided evidence of interrupted endemic measles transmission for a minimum of 36 months, indicating sustained elimination.
Dual Elimination: Overall, 32 (60%) countries have achieved elimination status for both measles and rubella. Rubella elimination remains high, demonstrated by 49 (92%) Member States.
Root Cause Identified: The WHO/Europe spokesperson attributed the region-wide resurgence to "persistent immunity gaps," noting that the majority of reported cases occur among unimmunized individuals.
Policy Recommendation (Vaccination Coverage): The RVC reiterated the World Health Organization standard of "sustained coverage of at least 95% with 2 doses of measles- and rubella-containing vaccines" to achieve and maintain elimination.
Outbreak Response Deficiencies: The RVC expressed concern over “the absence of the timely detection of and adequate immunisation response to measles outbreaks,” stressing that improving response capabilities must be a priority for health systems.
Required Political Action: The RVC called for increased political and financial commitment at national and international levels to bolster immunization efforts, strengthen surveillance, and specifically target vulnerable and hard-to-reach under-vaccinated communities.